אדסל פוליו
Country: Իսրայել
language: եբրայերեն
source: Ministry of Health
documentation_request_send
active_ingredient:
DIPHTHERIA TOXOID; FILAMENTOUS HAEMAGGLUTININ (FHA); FIMBRAE TUPES 2 + 3 (FIM); INACTIVATED POLIO VIRUS (IPV) TYPE 1; INACTIVATED POLIO VIRUS (IPV) TYPE 2; INACTIVATED POLIO VIRUS (IPV) TYPE 3; PERTACTIN (PRN); PERTUSSIS TOXOID VACCINE; TETANUS TOXOID
MAH:
SANOFI ISRAEL LTD
ATC_code:
J07CA02
pharmaceutical_form:
תרחיף להזרקה
composition:
FIMBRAE TUPES 2 + 3 (FIM) 5 MCG/DOSE; PERTUSSIS TOXOID VACCINE 2.5 MCG/DOSE; FILAMENTOUS HAEMAGGLUTININ (FHA) 5 MCG/DOSE; PERTACTIN (PRN) 3 MCG/DOSE; DIPHTHERIA TOXOID 2 LF / 1 DOSES; TETANUS TOXOID 5 LF / 1 DOSES; INACTIVATED POLIO VIRUS (IPV) TYPE 1 40 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 2 8 DU/DOSE; INACTIVATED POLIO VIRUS (IPV) TYPE 3 32 DU/DOSE
administration_route:
תוך-שרירי
prescription_type:
מרשם נדרש
manufactured_by:
SANOFI PASTEUR, FRANCE
therapeutic_group:
DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
therapeutic_area:
DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS
therapeutic_indication:
Active immunization against diphtheria, tetanus, pertussis and poliomyelitis in subjects aged 3 years and over as a booster following primary immunisation . Adacel polio is not indicatd for primary immunisation. Adacel polio is not indicated for treating diseases caused by B. pertussis, C.Diphtheriae or c. tetani or by poliomyelitis infections.
authorization_date:
2015-01-31
